Investigation of carbapenem heteroresistance among different sequence types of Pseudomonas aeruginosa clinical isolates reveals further diversity

Journal of Medical Microbiology

Volumn 60, Issue 10, 2011, Pages 1556-1558

  Oikonomou, Olga ^a   Panopoulou, Maria ^b   Ikonomidis, Alexandros ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM; BETA LACTAMASE AMPC; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PORIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM ISOLATE; EPSILOMETER TEST; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HOSPITAL INFECTION; MEXE GENE; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NOTE; OPRD GENE; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REGULATORY MECHANISM;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; GENETIC VARIATION; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 80053145956     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.032276-0     Document Type: Note

References (10)

1. Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. (2004). Bacterial persistence as a phenotypic switch. Science 305, 1622-1625.
2. CLSI (2008). Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement. M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
3. Curran, B., Jonas, D., Grundmann, H., Pitt, T. & Dowson, C. G. (2004). Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42, 5644-5649.
4. Falagas, M. E., Makris, G. C., Dimopoulos, G. & Matthaiou, D. K. (2008). Heteroresistance: a concern of increasing clinical significance? Clin Microbiol Infect 14, 101-104.
5. Ikonomidis, A., Tsakris, A., Kantzanou, M., Spanakis, N., Maniatis, A. N. & Pournaras, S. (2008). Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa. FEMS Microbiol Lett 279, 36-39.
6. Libisch, B., Poirel, L., Lepsanovic, Z., Mirovic, V., Balogh, B., Pászti, J., Hunyadi, Z., Dobák, A., Füzi, M. & Nordmann, P. (2008). Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. FEMS Immunol Med Microbiol 54, 330-338.
7. Lister, P. D., Wolter, D. J. & Hanson, N. D. (2009). Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 22, 582-610.
8. Nemec, A., Krizova, L., Maixnerova, M. & Musilek, M. (2010). Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic. Res Microbiol 161, 234-242.
9. Pournaras, S., Ikonomidis, A., Markogiannakis, A., Spanakis, N., Maniatis, A. N. & Tsakris, A. (2007). Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J MedMicrobiol 56, 66-70.
10. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.